Pharmaceutical Preparations · DE · CIK 1048477
BioMarin develops and commercializes medicines for people with genetically defined rare diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 11, 2026: 3 sold $3.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Sell | 16,486 | $60.46 | $997K |
| Feb 26, 2026 | Davis George EricEVP, Chief Legal Officer | Sell | 26,061 | $61.36 | $1.6M |
| Feb 26, 2026 | Friberg Gregory REVP, Chief R&D Officer | Sell | 6,326 | $60.38 | $382K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.